Ondansetron (Zofran, etc) will join the list of drugs getting stronger warnings about "QT prolongation"

Ondansetron (Zofran, etc) will join the list of drugs getting stronger warnings about "QT prolongation."

If you think you are hearing more about "QT warnings" these days than ever before, you're right. This upswing in QT warnings is partly due to FDA's effort to alert people to meds that can change heart rhythm.

You recently heard about QT problems with Seroquel and Celexa. These meds can change the way a person's heart beats...by prolonging the "QT interval" on an EKG and increasing the risk for sudden death.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote